Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4614

1.

Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.

McLean E, Price A, Chihana M, Kayuni N, Marston M, Koole O, Zaba B, Crampin A; ALPHA Network.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):391-398. doi: 10.1097/QAI.0000000000001395.

2.

Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.

Mugwanya KK, John-Stewart G, Baeten J.

Expert Opin Drug Saf. 2017 Jul;16(7):867-871. doi: 10.1080/14740338.2017.1338271. Epub 2017 Jun 8. Review.

PMID:
28571500
3.

Facial botryomycosis-like pyoderma in an HIV-infected patient: remission after initiation of darunavir and raltegravir.

Eyer-Silva WA, Silva GARD, Ferry FRA, Pinto JFDC.

Rev Soc Bras Med Trop. 2017 Mar-Apr;50(2):277-279. doi: 10.1590/0037-8682-0061-2016.

4.

90-90-90-Plus: Maintaining Adherence to Antiretroviral Therapies.

Corless IB, Hoyt AJ, Tyer-Viola L, Sefcik E, Kemppainen J, Holzemer WL, Eller LS, Nokes K, Phillips JC, Dawson-Rose C, Rivero-Mendez M, Iipinge S, Chaiphibalsarisdi P, Portillo CJ, Chen WT, Webel AR, Brion J, Johnson MO, Voss J, Hamilton MJ, Sullivan KM, Kirksey KM, Nicholas PK.

AIDS Patient Care STDS. 2017 May;31(5):227-236. doi: 10.1089/apc.2017.0009.

PMID:
28514193
5.

A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.

Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

PLoS Med. 2017 May 2;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. eCollection 2017 May.

6.

[Antiretroviral therapy containing raltegravir in HIV-infected pregnant women: Systematic review].

García-Fernández L, Fiestas F, Vásquez R, Benites C.

Rev Chilena Infectol. 2016 Oct;33(Suppl 1):60-66. doi: 10.4067/S0716-10182016000700007. Review. Spanish.

7.

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.

Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, Goulart S, Torres TS, Marins LMS, Anderson PL, Luz PM, Costa Leite ID, Liu AY, Veloso VG, Grinsztejn B; PrEP Brasil Study Team Clinical Trial Number 01989611.

J Int AIDS Soc. 2017 Apr 6;20(1):1-14. doi: 10.7448/IAS.20.1.21472.

8.

Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study.

Flax VL, Hamela G, Mofolo I, Hosseinipour MC, Hoffman IF, Maman S.

PLoS One. 2017 Apr 14;12(4):e0175590. doi: 10.1371/journal.pone.0175590. eCollection 2017.

9.

Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges.

Technau KG, Kuhn L, Coovadia A, Carmona S, Sherman G.

J Int AIDS Soc. 2017 Apr 10;20(1):1-8. doi: 10.7448/IAS.20.01/21436.

10.

Lower genetic variability of HIV-1 and antiretroviral drug resistance in pregnant women from the state of Pará, Brazil.

Machado LF, Costa IB, Folha MN, da Luz AL, Vallinoto AC, Ishak R, Ishak MO.

BMC Infect Dis. 2017 Apr 12;17(1):270. doi: 10.1186/s12879-017-2392-y.

11.

Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.

Patel RC, Baeten JM, Heffron R, Hong T, Davis NL, Nanda K, Coombs RW, Lingappa JR, Bukusi EA, Hurst S, Thomas KK, Kourtis AP, Mugo N; Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):91-96. doi: 10.1097/QAI.0000000000001339.

PMID:
28399558
12.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study.

Carter A, de Pokomandy A, Loutfy M, Ding E, Sereda P, Webster K, Nicholson V, Beaver K, Hogg RS, Kaida A; CHIWOS Research Team.

BMC Res Notes. 2017 Mar 24;10(1):138. doi: 10.1186/s13104-017-2453-8.

13.

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys.

Abongomera G, Kiwuwa-Muyingo S, Revill P, Chiwaula L, Mabugu T, Phillips AN, Katabira E, Chan AK, Gilks C, Musiime V, Hakim J, Kityo C, Colebunders R, Gibb DM, Seeley J, Ford D; Lablite Project Team.

Int Health. 2017 Mar 1;9(2):91-99. doi: 10.1093/inthealth/ihx006.

PMID:
28338914
14.

[Serological and nutritional outcome of infants born to HIV positive mothers undergoing option B + therapy in Guédiawaye].

Baptiste DJ, Djibril D, Assane S, Ngagne M, Baly O, Ousmane N.

Pan Afr Med J. 2016 Dec 7;25:224. doi: 10.11604/pamj.2016.25.224.10441. eCollection 2016. French.

15.

Live with the Disease Like You Used to Before You Knew You Were Infected: A Qualitative Study Among 10-Year Survivors Living with HIV in Haiti.

Pierre S, Riviera V, Jean CP, Louis MJ, Reif LK, Severe P, Rouzier V, Johnson WD, Pape JW, Fitzgerald DW, McNairy ML, Boutin-Foster C.

AIDS Patient Care STDS. 2017 Mar;31(3):145-151. doi: 10.1089/apc.2016.0192.

PMID:
28282245
16.

Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.

Scott GB, Brogly SB, Muenz D, Stek AM, Read JS; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team.

Obstet Gynecol. 2017 Apr;129(4):621-628. doi: 10.1097/AOG.0000000000001929.

PMID:
28277349
17.

Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.

Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Bedoya LM, Tamayo A, Rubio J, Veiga MD.

Mar Drugs. 2017 Feb 21;15(2). pii: E50. doi: 10.3390/md15020050.

18.

Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.

Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, Carmona S, Sherman G, Fox MP.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):383-389. doi: 10.1097/QAI.0000000000001284.

PMID:
28225717
19.

UK national clinical audit: management of pregnancies in women with HIV.

Raffe S, Curtis H, Tookey P, Peters H, Freedman A, Gilleece Y; British HIV Association Audit and Standards Sub-Committee.

BMC Infect Dis. 2017 Feb 20;17(1):158. doi: 10.1186/s12879-017-2255-6.

20.

Placental pathology in HIV infection at term: a comparison with HIV-uninfected women.

Kalk E, Schubert P, Bettinger JA, Cotton MF, Esser M, Slogrove A, Wright CA.

Trop Med Int Health. 2017 May;22(5):604-613. doi: 10.1111/tmi.12858. Epub 2017 Mar 16.

PMID:
28214384

Supplemental Content

Loading ...
Support Center